Purdue Pharma's Sentencing for Opioid Charges Delayed for Public Participation
A federal judge has delayed the sentencing of Purdue Pharma by one week to allow more public participation in the case concerning the company's role in the opioid crisis. The sentencing, initially scheduled to occur via Zoom, was postponed after public protests and demands for in-person participation. Purdue had previously pleaded guilty to charges related to the aggressive marketing of opioids, contributing to an epidemic that has claimed over a million lives in the U.S. The company faces a $3.5 billion criminal fine and $2 billion in criminal forfeiture, with most fines going unpaid under a settlement agreement. 
